Nimesulide alters cell recruitment into mitosis in murine intestinal crypts without influencing the cell production rate

Digestive Diseases and Sciences

Volumn 52, Issue 6, 2007, Pages 1471-1478

  McGarvey, M Alice ^a   Bass, Gary ^a   Ettarh, R R ^b  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Epithelium; Indomethacin; Intestine; Kinetics; Nimesulide; NSAIDs; Proliferation

Indexed keywords

INDOMETACIN; NIMESULIDE; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COMPARTMENTALIZATION; CELL KINETICS; CONTROLLED STUDY; CRYPT CELL; DOWN REGULATION; INTESTINE CONTRACTION; INTESTINE EPITHELIUM; INTESTINE MUCOSA; INTESTINE VILLUS; MALE; MITOSIS INHIBITION; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE MUCOSA;

ANIMALS; CELL PROLIFERATION; CYCLOOXYGENASE INHIBITORS; INDOMETHACIN; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MICE; MITOSIS; SULFONAMIDES;

EID: 34248641974     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9572-8     Document Type: Article

References (42)

1. Kent TH, Cardelli RM, Stamler FW (1969) Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol 54:237-245
2. Bjarnason I, Zanelli G, Smith T, Smethurst P, Price AB, Gumpel MJ, Levi AJ (1987) The pathogenesis and consequence of non steroidal anti-inflammatory drug induced small intestinal inflammation in man. Scand J Rheumatol (Suppl) 64:55-62
3. Ettarh RR, Carr KE (1993) Structural and morphometric analysis of murine small intestine after indomethacin administration. Scand J Gastroenterol 28:795-802
4. Anthony A, Dhillon AP, Thrasivlulou C, Pounder RE, Wakefield AJ (1995) Pre-ulcerative villous contraction and microvascular occlusion induced by indomethacin in the rat jejunum: a detailed morphological study. Aliment Pharmacol Ther 9:605-613
5. Tanaka A, Hase S, Miyazawa T, Ohno R, Takeuchi K (2002) Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events. J Pharmacol Exp Ther 303:1248-1254
6. Smith WL (1989) The eicosanoids and their biochemical mechanisms of action. Biochem J 259:315-324
7. Whittle BJ (2004) Mechanisms underlying intestinal injury induced by anti-inflammatory COX inhibitors. Eur J Pharmacol 500:427-439
8. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM (1993) Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 268:9049-9054
9. Schmedtje JF, Ji YS, Liu, WL, DuBois RN, Runge MS (1997) Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 272:601-608
10. Adderley SR, Fitzgerald DJ (1999) Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. J Biol Chem 274:5038-5046
11. Halter F, Tarnawski AS, Schmassmann A, Peskar BM (2001) Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Gut 49:443-453
12. Lesch CA, Gilbertsen RB, Song Y, Dyer RD, Schrier D, Kraus ER, Sanchez B, Guglietta A (1998) Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats. J Pharmacol Exp Ther 287:301-306
13. Shigeta J, Takahashi S, Okabe S (1998) Role of cyclooxygenase-2 in the healing of gastric ulcers in rats. J Pharmacol Exp Ther 286:1383-1390
14. Blikslager AT, Zimmel DN, Young KM, Campbell NB, Little D, Argenzio RA (2002) Recovery of ischaemic injured porcine ileum: evidence for a contributory role of COX-1 and COX-2. Gut 50:615-623
15. Uribe A, Alam M, Midtvedt T (1992) E2 prostaglandins modulate cell proliferation in the small intestinal epithelium of the rat. Digestion 52:157-164
16. Uribe A, Alam M, Winell-Kapraali M (1995) Indomethacin inhibits cell proliferation and increases cell losses in rat gastrointestinal epithelium. Dig Dis Sci 40:2490-2494
17. Uribe A, Alam M, Soderman C (1997) Cell kinetic events in early indomethacin-induced gastrointestinal ulcerations in the rat. Eur J Gastroenterol Hepatol 9:267-273
18. Buecher B, Broquet A, Bouancheau D, Heymann MF, Jany A, Denis MG, Bonnet C, Galmiche JP, Blottiere HM (2003) Molecular mechanisms involved in the antiproliferative effect of two COX-2 inhibitors, nimesulide and NS-398, on colorectal cancer cell lines. Dig Liver Dis 35:557-565
19. Kohno H, Suzuki R, Sugie S, Tanaka T (2005) Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands. BMC Cancer 5:46
20. McGarvey MA, O'Kelly F, Ettarh RR (2006) Nimesulide inhibits crypt epithelial cell proliferation at 6 hours in the small intestine in CD-1 mice. Dig Dis Sci (in press)
21. Goodlad RA, Wright NA (1982) Quantitative studies on epithelial replacement in the gut. In: Titchen TA (ed) Techniques in life sciences-digestive physiology. Elsevier, Clare, pp 1-23
22. Wright NA, Appleton DR (1980) The metaphase arrest technique: a critical review. Cell Tissue Kinet 13:643-663
23. Ettarh RR, Carr KE (1996) Morphometric analysis of the small intestinal epithelium in the indomethacin-treated mouse. J Anat 189:51-56
24. Sigthorsson G, Jacob M, Wrigglesworth J, Somasundaram S, Tavares I, Foster R, Roseth A, Rafi S, Mahmud T, Simpson R, Bjarnason I (1998) Comparison of indomethacin and nimesulide, a selective cyclooxygenase-2 inhibitor, on key pathophysiologic steps in the pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in the rat. Scand J Gastroenterol 33:728-735
25. Toutain PL, Cester CC, Haak T, Metge S (2001) Pharmacokinetic profile and in vitro selective cyclooxygenase-2 inhibition by nimesulide in the dog. J Vet Pharmacol Ther 24:35-42
26. Sigthorsson G, Simpson RJ, Walley M, Anthony A, Foster R, Hotz-Behoftsitz C, Palizban A, Pombo J, Watts J, Morham SG, Bjarnason I (2002) COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice. Gastroenterology 122:1913-1923
27. Uribe A (1993) Indomethacin inhibits cell proliferation in the oxyntic epithelium of the rat. Prostaglandins 45:15-26
28. Anthony A, Pounder RE, Dhillon AP, Wakefield AJ (1997) Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin. Gut 41:763-770
29. Uribe A, Rubio C, Johansson C (1988) Alternating proliferative capacity in the rat gastrointestinal mucosa. Effects of E2 prostaglandins and indomethacin. Scand J Gastroenterol 23:163-170
30. Penney AG, Malcontenti-Wilson C, O'Brien PE, Andrews FJ (1995) NSAID-induced delay in ulcer healing is not associated with decreased epithelial cell proliferation in rats. Dig Dis Sci 40(12):2684-2693
31. Langenbach R, Loftin CD, Lee C, Tiano H (1999) Cyclooxygenase-deficient mice: a summary of their characteristics and susceptibilities to inflammation and carcinogenesis. Ann NY Acad Sci 889:52-61
32. Shah AA, Thjodleifsson B, Murray FE, Kay E, Barry M, Sigthorsson G, Gudjonsson H, Oddsson E, Price AB, Fitzgerald DJ, Bjarnason I (2001) Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen. Gut 48:339-346
33. Tanaka A, Araki H, Komoike Y, Hase S, Takeuchi K (2001) Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs. J Physiol Paris 95:21-27
34. Kopp E, Ghosh S (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265:956-959
35. Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM, Chen CS (2000) The cyclooxygenase-2 inhibitor celcecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem 275:11397-11403
36. Marra DE, Simoncini T, Liao JK (1994) Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by up-regulation of p21 (Waf1) and p27 (Kip1). Circulation 102:2124-2130
37. Li JY, Wang XZ, Chen FL, Yu JP, Luo HS (2003) Nimesulide inhibits proliferation via induction of apoptosis and cell cycle arrest in human gastric adenocarcinoma cell line. World J Gastroenterol 9:915-920
38. Kucab JE, Lee C, Chen CS, Zhu J, Gilks CB, Cheang M, Huntsman D, Yorida E, Emerman J, Pollak M, Dunn SE (2005) Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours. Breast Cancer Res 7(5):R796-R807
39. Takeuchi K, Miyazawa T, Tanaka A, Kato S, Kunikata T (2002) Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats. Digestion 66:30-41
40. Fornai M, Blandizzi C, Colucci R, Antonioli L, Bernardini N, Segnani C, Baragatti B, Barogi S, Berti P, Spisni R, Del Tacca M (2005) Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice. Gut 54(5):608-616
41. Yokota A, Taniguchi M, Tanaka A, Takeuchi K (2005) Development of intestinal, but not gastric damage caused by a low dose of indomethacin in the presence of rofecoxib. Inflammopharmacology 13(1-3):209-216
42. Cheng H, Leblond CP (1974) Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian theory of the origin of the four epithelial cell types. Am J Anat 141:537-561